Medicines
Discover all available medicines and treatments
Discover all available medicines and treatments
Brand: PhosLo, Calphron, Eliphos
Calcium acetate is a phosphate binder used to treat hyperphosphatemia (high phosphate levels) in patients with end-stage renal disease (ESRD). It works by binding to dietary phosphate in the gastrointestinal tract, preventing its absorption into the bloodstream. It belongs to the class of drugs known as phosphate binders and is administered orally.
Used to reduce phosphate levels in patients with end-stage renal disease.
Outcome:
Reduced antibiotic absorption
Mechanism:
Chelation
Outcome:
Increased risk of digoxin toxicity
Mechanism:
Altered electrolyte balance
Outcome:
Reduced antacid effectiveness
Mechanism:
Neutralization
Most likely new formulation: Chewing gum formulation for increased patient compliance (2026, 60% confidence).
Based on current usage trends and clinical trial data, the likelihood of calcium acetate remaining a standard treatment for hyperphosphatemia is high (85%).
Phosphate Binder, Mineral Supplement
Calcium Salt